Icon to Acquire Clinical Trial Services Division for $52m
Icon has agreed to purchase the clinical trials services division of Cross Country Healthcare for $52m to primarily expand its staffing, pharmacovigilance and drug safety services.
Archives for February 5, 2013
Aduro focus on combinations in purchase of GVAX vaccines
Aduro says “combinations are the future” after bolstering its immunotherapy portfolio.
CMOs, CROs will Report Payments to Doctors Under Final 'Sunshine' Rule
CMOs and CROs must notify sponsors of payments made to physicians on their behalf under long-awaited US 'Sunshine' rules published last week.
Pharma Cargo Theft Down to Lowest Recorded Levels
The US pharma industry in 2012 saw the lowest number of reported cargo thefts and the lowest average value per incident since the data collection began in 1996.
Lonza rejigs ops and says more changes are to follow
Lonza has reorganised its operations into two new divisions – Pharma and Specialty ingredients – and says more changes are on the way.
update
Trials published by Pfizer didn't match internal docs say researchers calling for CONSORT revision
Clinical trials made public by Pfizer did not match internal reports or reflect what was done in studies of the seizure drug gabapentin say researchers calling for revision of journal publishing codes.
Alnylam and The Medicines Company collaborate on RNAi technology
With Angiomax potentially going generic in 2015, The Medicines Company has collaborated with Alnylam over a 'pragmatic' high cholesterol drug to aid future growth.